We ensure that products manufactured and distributed by us, consistently meet predetermined quality specifications and our customer expectations. We believe in continual improvement of our products and processes through training and innovation.
Shalina has registered a number of essential medicines with the MOH in Kenya, across a range of therapeutic categories, including anti-infectives, anthelmintics and analgesics. We have additional significant pipeline of products under registration.
Shalina manufacturing plant is approved by the Pharmacy and poison boards of Kenya and the company currently distribute the pharmaceutical products across Kenya through its own distribution network in Kenya. Our team work across Kenya to promote our medicine and deliver continuous medical education.
Shalina has recently acquired the Brands of one of the leading pharmaceutical company in Kenya – PMC (Pharmaceutical Manufacturing Company). Brands acquired from PMC will help Shalina to enter the Kenya market and expand its reach in eastern African market. PMC brands has very strong Equity in Kenya and have leadership position in their various therapeutic area. The acquisition is in line to Shalina Healthcare long term strategy of making East Africa as one of its biggest market. Some of the brands acquired are Clozol B , Pharmasal , Betason etc.
Please contact our Kenya Team at Kenya@shalina.com
- Full name: The Republic of Kenya
- Population: 49.7 million (UN, 2017)
- Capital: Nairobi
- Area: 580,367 km2 (224,081 sq mi)
- Major languages: Swahili, English
- Major religion: Christianity
- Monetary unit: 1 kwanza = 100 lwei
- Main exports: coffee, petroleum products, fish, cement, pyrethrum, and sisal.
- GNI per capita: US $3,250 (World Bank, 2011)